# A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting

> **NCT02546869** · PHASE3 · WITHDRAWN · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Lebrikizumab
- **DEVICE:** Prefilled Syringes

## Key facts

- **NCT ID:** NCT02546869
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09-29
- **Primary completion:** 2016-06-29
- **Final completion:** 2016-06-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn due to an internal decision.
- **Last updated:** 2018-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02546869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02546869, "A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02546869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*